← Back to headlines
The GLP-1 Paradox: High Cost vs. High Efficacy
The GLP-1 paradox highlights the challenge of these highly effective drugs being too expensive for widespread coverage, yet too beneficial to be overlooked in healthcare.
23 Jul, 11:30 — 23 Jul, 11:30
Sources
Showing 1 of 1 sources
